Sarcopenia and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Yupeng Wei , Xiaopeng Hu
{"title":"Sarcopenia and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study","authors":"Yupeng Wei ,&nbsp;Xiaopeng Hu","doi":"10.1016/j.ajpc.2025.101060","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Substantial evidence has demonstrated the correlation between sarcopenia and cardiovascular disease (CVD). However, it remains uncertain whether this correlation exists in individuals with cardiovascular-kidney-metabolic (CKM) syndrome.</div></div><div><h3>Methods</h3><div>This study used data from the China Health and Retirement Longitudinal Study (CHARLS). Sarcopenia state was determined according to the Asian Working Group for Sarcopenia 2019 criteria. Muscle mass was estimated by the height‐adjusted muscle mass. Cox proportional hazard models were employed to calculate the hazard ratio (HR) and 95 % confidence interval (95 % CI.</div></div><div><h3>Results</h3><div>A total of 7428 participants (mean age: 59.0 years; male: 47.6 %) were included in this study. Of these, non-sarcopenia, possible sarcopenia, and sarcopenia individuals were 4398 (59.2 %), 2162 (29.1 %), and 869 (11.7 %), respectively. During a median follow-up of 9.0 years, participants with possible sarcopenia (HR: 1.32, 95 % CI: 1.19–1.47) and sarcopenia (HR: 1.45, 95 % CI: 1.23–1.72) exhibited an increased risk of incident CVD compared to those with non-sarcopenia. Higher quintiles of muscle mass presented significantly increased risks of incident CVD than those with the lowest quintile (quintile 2: HR 1.34, 95 % CI 1.15–1.56; quintile 3: HR 1.41, 95 % CI 1.19–1.67; quintile 4: HR 1.71, 95 % CI 1.40–2.09; quintile 5: HR 2.20, 95 % CI 1.75–2.77). The dose-response curve indicated a positive linear association between muscle mass and incident CVD (P for overall &lt;0.001, P for nonlinear = 0.795).</div></div><div><h3>Conclusion</h3><div>Both possible sarcopenia and sarcopenia were associated with an increased risk of incident CVD among individuals with CKM syndrome stages 0–3.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"23 ","pages":"Article 101060"},"PeriodicalIF":4.3000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725001357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Substantial evidence has demonstrated the correlation between sarcopenia and cardiovascular disease (CVD). However, it remains uncertain whether this correlation exists in individuals with cardiovascular-kidney-metabolic (CKM) syndrome.

Methods

This study used data from the China Health and Retirement Longitudinal Study (CHARLS). Sarcopenia state was determined according to the Asian Working Group for Sarcopenia 2019 criteria. Muscle mass was estimated by the height‐adjusted muscle mass. Cox proportional hazard models were employed to calculate the hazard ratio (HR) and 95 % confidence interval (95 % CI.

Results

A total of 7428 participants (mean age: 59.0 years; male: 47.6 %) were included in this study. Of these, non-sarcopenia, possible sarcopenia, and sarcopenia individuals were 4398 (59.2 %), 2162 (29.1 %), and 869 (11.7 %), respectively. During a median follow-up of 9.0 years, participants with possible sarcopenia (HR: 1.32, 95 % CI: 1.19–1.47) and sarcopenia (HR: 1.45, 95 % CI: 1.23–1.72) exhibited an increased risk of incident CVD compared to those with non-sarcopenia. Higher quintiles of muscle mass presented significantly increased risks of incident CVD than those with the lowest quintile (quintile 2: HR 1.34, 95 % CI 1.15–1.56; quintile 3: HR 1.41, 95 % CI 1.19–1.67; quintile 4: HR 1.71, 95 % CI 1.40–2.09; quintile 5: HR 2.20, 95 % CI 1.75–2.77). The dose-response curve indicated a positive linear association between muscle mass and incident CVD (P for overall <0.001, P for nonlinear = 0.795).

Conclusion

Both possible sarcopenia and sarcopenia were associated with an increased risk of incident CVD among individuals with CKM syndrome stages 0–3.

Abstract Image

0-3期成人心血管-肾脏代谢综合征患者的肌肉减少症和心血管疾病:一项前瞻性队列研究
大量证据表明,肌肉减少症与心血管疾病(CVD)之间存在相关性。然而,尚不确定这种相关性是否存在于心血管肾代谢综合征(CKM)患者中。方法本研究采用中国健康与退休纵向研究(CHARLS)的数据。骨骼肌减少症状态根据2019年亚洲骨骼肌减少症工作组标准确定。肌肉质量由身高调整后的肌肉质量估计。采用Cox比例风险模型计算风险比(HR)和95%置信区间(95% CI)。结果共7428例受试者,平均年龄59.0岁;男性:47.6%)纳入本研究。其中,非肌少症、可能肌少症和肌少症患者分别为4398例(59.2%)、2162例(29.1%)和869例(11.7%)。在中位9年的随访期间,与非肌肉减少症患者相比,可能患有肌肉减少症(HR: 1.32, 95% CI: 1.19-1.47)和肌肉减少症(HR: 1.45, 95% CI: 1.23-1.72)的患者发生心血管疾病的风险增加。肌肉质量高的五分位数比肌肉质量低的五分位数发生心血管疾病的风险显著增加(五分位数2:HR 1.34, 95% CI 1.15-1.56;五分位数3:HR 1.41, 95% CI 1.19-1.67;四分位数:危险度1.71,95%可信区间1.40-2.09;五分位数:HR 2.20, 95% CI 1.75-2.77)。剂量-反应曲线显示肌肉质量与CVD事件呈正线性关系(总体P = 0.001,非线性P = 0.795)。结论在CKM综合征0-3期患者中,可能的肌肉减少症和肌肉减少症都与CVD发生风险增加相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信